GLP-1 Guide

Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.

Headspace Review: For the Eating a GLP-1 Doesn’t Touch

$69.99 a year with a fortnight free — one of the cheaper things on this site, and pointed at something real. These medications are excellent at removing physiological hunger and do nothing about eating driven by stress, boredom or habit. What an app cannot do is treat a mental health condition, and there is a specific reason that matters here.

If your mood has changed since starting the medication, call your prescriber

Labelling for GLP-1 receptor agonists prescribed for weight management advises monitoring for depression, suicidal thoughts, and unusual changes in mood or behaviour, and advises discontinuing and contacting a healthcare provider if they occur. If you have noticed low mood, hopelessness or thoughts of harming yourself since starting or increasing your dose, that is an urgent conversation with the person who prescribed it. A meditation app is not the response to that, and downloading one should not delay the call by a single day.

Our Verdict

Headspace · headspace.com · $69.99/yr or $12.99/mo

4 / 5

Cheap, with generous trials and no lock-in

$69.99 a year after 14 days free, or $12.99 monthly after 7 days free, with cancel anytime stated on the page. Against the things we usually review — $2,388 a year for remote coaching, $4,295 for a home gym, $54.99 a month for a fat burner that duplicates your prescription — this is a rounding error.

It targets the part of eating the drug leaves behind

GLP-1 medication removes physiological hunger with remarkable effectiveness. It does not remove eating that was never about hunger — stress, boredom, habit, the automatic 9pm trip to the kitchen. Those patterns sit underneath and tend to resurface if the pharmacological suppression ever stops, which makes working on them while you have the breathing room a sensible use of a year.

The evidence is real but more modest than the category implies

Mindfulness-based approaches have a genuine research base for perceived stress, and mindfulness-based eating interventions have shown benefit for binge and emotional eating. Whether a consumer app reproduces what a structured clinician-delivered programme achieves is a different and weaker question. Buy it as something that may help, not as a known quantity.

Annual auto-renewal is where subscriptions hide

The page states the annual subscription renews automatically each year after the trial. Fourteen days is a generous trial and twelve months is a long time to remember a decision. Set a calendar reminder on day 12, and another before the renewal date, or take the monthly plan while you find out whether you will use it.

Affiliate disclosure: we are paid 10% — around $7 on an annual subscription. This page notes that free alternatives exist and that the app is not a treatment.

Editor's PickRecommended Partner

Our Top Recommended Provider: CoreAge Rx

After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:

  • Flat-Rate Pricing

    Same cost at every dose level — no price jumps as you titrate up.

  • Verified Pharmacies

    US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.

  • Everything Included

    Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.

💬

Active Community of Members

Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.

Visit CoreAge Rx →

$69.99

Per year — $5.83 a month

14 days

Free trial on the annual plan

$12.99

Monthly, with 7 days free

Not a

treatment for a mental health condition

What the medication does, and what it leaves for you

One of the most striking things people report on these drugs is not weight loss but silence. The persistent background negotiation about food — what is in the cupboard, what you will have later, whether you have earned it — quietens down. That effect is real, it is pharmacological, and it explains a great deal of why these medicines work where willpower did not. But it is worth being precise about what has been switched off, because it is not everything.

What has quietened is physiological hunger and the reward signalling attached to it. What has not necessarily changed is eating that was never about hunger in the first place: eating because a day was awful, because you are bored on a Sunday afternoon, because someone brought cake into the office, or simply because it is nine in the evening and that is when you eat something. Those are habits and coping mechanisms, they were learned over years, and a drug that reduces appetite does not unlearn them. Many people find they can still eat when they are not hungry — they just do it less often, and notice it more.

That gap is the honest case for something like Headspace, and it is a better case than most wellness purchases can make. Mindfulness-based approaches have a real research base for perceived stress, and mindfulness-based interventions aimed specifically at eating have shown benefit for binge and emotional eating — the mechanism being that noticing an urge without immediately acting on it is a trainable skill. While the medication is doing the heavy lifting on hunger, you have unusual space to work on the part it does not touch. If the drug is ever stopped, that work is what remains.

We would keep expectations proportionate. The evidence that a consumer app delivers what a structured, clinician-delivered mindfulness programme delivers is considerably weaker than the evidence for the underlying approach, and the honest framing is that $69.99 buys a well-made tool that may help rather than an intervention with a known effect size. If emotional eating is significant enough to be distressing — if it feels compulsive, or is followed by shame, or involves eating past discomfort — that is a reason to talk to a clinician about it, because structured therapy exists and works better than an app.

One boundary to hold firmly, and it is the reason this review carries a warning at the top. Labelling for these medications advises monitoring for depression, suicidal thoughts and unusual changes in mood or behaviour, and advises discontinuing and contacting a healthcare provider if they arise. A meditation subscription is not a response to a change in mood on a new medication. If that is what is happening, the app can wait and the phone call cannot.

In its favour

  • $69.99 a year is genuinely cheap next to almost everything else reviewed on this site.
  • Fourteen days free on annual and seven on monthly — enough to find out whether you will use it.
  • Cancel anytime stated plainly, with pricing published clearly on one page.
  • Aimed at a real gap: the eating that appetite suppression does not reach.
  • Mindfulness has a genuine research base for stress, and some for emotional and binge eating.
  • Content spans sleep, focus and movement as well as meditation, and student and family plans exist.
  • robots.txt permits crawling with no restrictions on AI agents.

Against it

  • Not a treatment for depression, anxiety or an eating disorder, and should not delay clinical help.
  • Evidence for consumer apps is weaker than for the clinician-delivered programmes they draw on.
  • Annual auto-renewal on a twelve-month cycle is easy to forget after a 14-day trial.
  • Free guided meditation is widely available, so the paid version buys structure rather than access.
  • Sleep content is not CBT-I, and is the wrong first step if apnoea has not been excluded.
  • We did not price the separate mental health coaching product or read its terms.

Related reading

If sleep is your actual problem, read our piece on why poor sleep plus excess weight warrants testing for obstructive sleep apnoea before any sedating product — and note that one GLP-1 drug now carries an approval for it. Sleep, apnoea and sedation.

Our verdict: 4.0 out of 5

Cheap, honestly sold, and aimed at the part of eating your prescription does not reach — just do not mistake it for treatment.

Most things we review here are expensive and aimed at something the reader's medication already does better. This is the opposite: $69.99 a year, aimed squarely at something the medication does not do at all. GLP-1 drugs are remarkably good at quietening physiological hunger. They do not unlearn eating that was never about hunger — the stressful day, the boredom, the automatic nine o'clock visit to the kitchen. Those are habits built over years, they are still there, and they are what tends to resurface if the drug is ever stopped.

Working on that while the pharmacology is holding the line is a genuinely sensible use of a year, and mindfulness is a defensible tool for it. The research base for perceived stress is real, and mindfulness-based interventions aimed at eating have shown benefit for binge and emotional eating, on the reasonable mechanism that noticing an urge without acting on it is a skill that can be practised. We would not claim more than that: the evidence that a consumer app matches a clinician-delivered programme is weaker, and $69.99 buys a well-made tool that may help rather than a known quantity.

Commercially it is straightforward and cheap. Fourteen days free then $69.99 annually, or seven days free then $12.99 monthly, cancel anytime, pricing on one page. The only thing to watch is the annual auto-renewal, which the page discloses — a fortnight's trial followed by a twelve-month cycle is exactly the shape of subscription people forget they have. Set a reminder on day twelve, and take the monthly plan if you are unsure. And it is worth saying that free guided meditation is abundant; what you are paying for is structure and production, which does help some people persist.

Four out of five, with two boundaries that matter more than the price. First, an app is not a treatment for depression, anxiety or an eating disorder — if emotional eating feels compulsive, is followed by shame, or involves eating past discomfort, that warrants a clinician, because structured therapy exists and works better. Second, and more urgently, labelling for these medications advises monitoring for depression, suicidal thoughts and unusual mood changes, and advises stopping and contacting a healthcare provider if they occur. If your mood has shifted since starting or increasing your dose, that is a phone call today, not a meditation. We earn about $7 if you subscribe, and nothing at all for that last paragraph, which is the most important one here.

Frequently asked questions

What does Headspace cost?

Checked 12 August 2026 on its own subscriptions page: $69.99 a year with a 14-day free trial, which it presents as $5.83 a month, or $12.99 a month with a 7-day free trial. The annual plan renews automatically each year, and the page states you can cancel anytime. Student and family plans are offered separately, and there is a mental health coaching product we did not price.

Why would this be relevant on a GLP-1?

Because of the eating the medication does not reach. GLP-1 receptor agonists are extremely effective at reducing physiological hunger and what people describe as food noise. What they do not do is address eating that has nothing to do with hunger — eating because you are stressed, bored, upset, or because it is 9pm and that is simply what you do at 9pm. Those patterns are behavioural, they are still there underneath, and they tend to reassert themselves if the pharmacological suppression ever stops.

Is there evidence mindfulness helps with that?

Reasonable evidence for stress, more modest evidence for eating behaviour, and we would not oversell either. Mindfulness-based approaches have a real research base for perceived stress and for general wellbeing, and mindfulness-based eating interventions have shown some benefit for binge and emotional eating specifically. What is weaker is evidence that a consumer meditation app produces the same results as a structured programme delivered by a clinician. Treat it as a low-cost thing that may help rather than a treatment with a known effect size.

Can it treat depression or anxiety?

No, and this is the boundary that matters most. A meditation app is a wellbeing product, not a treatment for a mental health condition. If you have persistent low mood, anxiety that interferes with daily life, or thoughts of harming yourself, that needs a clinician rather than an app — and the app is not a reason to delay making that call.

Is there a specific mental health warning for GLP-1 users?

Yes, and it is important enough to state plainly. Labelling for GLP-1 receptor agonists prescribed for weight management advises monitoring for depression, suicidal thoughts or unusual changes in mood or behaviour, and advises discontinuing and contacting a healthcare provider if these occur. If you notice a change in your mood since starting or increasing your medication, that is a conversation with your prescriber, urgently — not something to meditate through. No app substitutes for that.

What about using it for sleep?

It is a reasonable adjunct and the wrong first step if your sleep is genuinely poor. Headspace offers sleepcasts, sleep music and audio experiences, and plenty of people find them helpful for winding down. But if you carry excess weight and sleep badly, the first question is whether you have obstructive sleep apnoea, which is common, underdiagnosed and not addressed by a sleep story. And for chronic insomnia the first-line treatment is cognitive behavioural therapy for insomnia, which is a structured clinical protocol rather than a relaxation track.

Are the free trials genuine?

They appear generous by the standards of this category — 14 days on the annual plan and 7 on monthly. The thing to note is what happens after: the page states that following the free trial the annual subscription is $69.99 and automatically renews each year. Annual auto-renewal is where subscriptions quietly persist, so if you are trialling it, set a reminder before day 14 rather than relying on remembering in twelve months.

Is $69.99 a year good value?

By the standards of what we review here, yes. That is less than two months of most GLP-1 supplement subscriptions we have looked at, a fraction of the $2,388 a year for remote personal training, and a small figure against a $4,295 home gym. If it makes you handle stress marginally better and you actually use it, the arithmetic is easy. The risk is not the price — it is paying $69.99 annually for something you opened twice.

Is there a free alternative?

Several, and it would be dishonest not to say so. Free guided meditations exist in abundance, some health systems and employers provide mindfulness resources at no cost, and the basic practice does not require an app at all. What you are paying for here is structure, progression and production quality, which genuinely helps some people stick with it. Try the free trial before assuming you need the paid version.

How much do you earn from this?

Ten per cent — about $7 on an annual subscription. Small enough that it has shaped nothing here, which is just as well given that this page tells readers a free alternative exists and that the app cannot treat a mental health condition.

Use the trial, set the reminder

Fourteen days free is long enough to find out whether you will actually use it — set a reminder on day twelve, because the annual plan renews automatically. And if your mood has changed since starting your medication, speak to your prescriber before anything else.

Visit Headspace (affiliate link)

Pricing verified 12 August 2026 and subject to change.

Mental health note

This article is informational and is not medical advice. A meditation or wellbeing app is not a treatment for depression, anxiety disorders, eating disorders or any other mental health condition, and should never delay seeking clinical care. Labelling for GLP-1 receptor agonists indicated for chronic weight management advises monitoring for depression, suicidal thoughts or behaviour, and unusual changes in mood or behaviour, and advises discontinuing the medication and contacting a healthcare provider if these occur; discuss any mood change since starting or escalating treatment with your prescriber promptly. If you are having thoughts of suicide or self-harm, contact emergency services or a crisis line immediately — in the United States, the 988 Suicide and Crisis Lifeline is available by calling or texting 988. Eating that feels compulsive or out of control, eating past discomfort, distress or shame around eating, or compensatory behaviours warrant assessment, as eating disorders occur in people of every body size and are treatable. Chronic insomnia is treated first-line with cognitive behavioural therapy for insomnia rather than relaxation content, and persistent poor sleep with excess weight warrants assessment for obstructive sleep apnoea.

Sources · date reviewed: 12 August 2026

  • headspace.com/subscriptions — rendered in a browser and retrieved 12 August 2026. Source for the pricing quoted: “Annual - 14 days free - $69.99” presented as “$5.83 USD/month” and marked Best value, and “Monthly - 7 days free - $12.99 USD/month”, together with the statement “After your free trial, the annual subscription is $69.99 USD and automatically renews each year” and the wording “Cancel anytime”. The page also references student and family pricing, a separate mental health coaching offering, and content categories of Sleep, Meditate, Move, Wake Up and Focus, including sleepcasts and audio experiences.
  • Katalys offer listing #1113, retrieved 12 August 2026 — 10.00% default commission.
  • headspace.com/robots.txt — retrieved 12 August 2026, 675 bytes, containing no restrictions on Anthropic or other AI crawlers.
  • Clinical context: GLP-1 receptor agonists reduce appetite and food-related reward signalling, which does not itself modify learned or emotionally driven eating behaviours. Mindfulness-based interventions have an established evidence base for reduction in perceived stress, and mindfulness-based eating interventions have demonstrated benefit for binge eating and emotional eating; evidence that consumer smartphone applications reproduce the effects of structured, facilitator-delivered programmes is more limited. Labelling for GLP-1 receptor agonists indicated for chronic weight management advises monitoring for depression, suicidal thoughts or behaviour and unusual changes in mood, with discontinuation and clinical contact advised if they occur. Cognitive behavioural therapy for insomnia is recommended as first-line treatment for chronic insomnia.

Limitations, stated plainly. We did not subscribe, use the app, or sample any of its content, so we make no assessment of the quality of the meditations, the interface, or how well the programme structure works in practice. We did not price or examine the separate mental health coaching product, the student plan or the family plan, and did not read the full terms and conditions or test the cancellation process. We did not assess Headspace's own published research or any specific efficacy claims it makes for its content; our comments on evidence concern mindfulness-based approaches generally rather than this product specifically, and should not be read as a finding about Headspace's effectiveness. We could not obtain an independent review-platform rating. We did not contact Headspace before publishing.

Affiliate disclosure

GLP1Drugs.org is paid a 10% commission on purchases made through the links on this page — roughly $7 on an annual subscription. We have rated Headspace 4.0 out of 5 on the basis of published pricing of $69.99 a year with 14 days free, aimed at a genuine gap that GLP-1 medication does not address; we have also noted that free guided meditation is widely available, that the annual plan auto-renews, that evidence for consumer apps is weaker than for clinician-delivered programmes, and — most importantly — that an app is not a treatment for a mental health condition and must not delay contacting a prescriber about mood changes on these medications. No company reviewed here sees or approves our copy before publication.